Scott Southwood

Title: Scott Southwood: Innovator in Immunogenic Peptides

Introduction

Scott Southwood is a prominent inventor based in Santee, California, known for his significant contributions to the field of immunology. With a total of 12 patents to his name, Southwood has made remarkable advancements in the development of artificial oligopeptides and their applications in inducing immune responses.

Latest Patents

Among his latest patents is the invention of PAN-DR binding polypeptides and their uses. This invention provides novel artificial oligopeptides capable of binding HLA Class II molecules encoded by several alleles. The oligopeptides include the sequence AXFVAAXTLXAXA (SEQ ID NO:1), wherein specific amino acids are selected from defined groups. The invention also encompasses large peptides comprising these oligopeptides, polynucleotides encoding them, and methods for inducing immune responses. Another significant patent focuses on HLA binding motifs and peptides, offering means and methods for selecting immunogenic peptides that can specifically bind glycoproteins encoded by HLA alleles. One such peptide, NMLSTVLGV (SEQ ID NO: 183), is particularly useful for eliciting an immune response against influenza.

Career Highlights

Scott Southwood has worked with notable companies in the biotechnology sector, including Epimmune Inc. and Pharmexa Inc. His work has been instrumental in advancing the understanding of immune responses and the development of therapeutic peptides.

Collaborations

Southwood has collaborated with esteemed colleagues in his field, including Alessandro D. Sette and John Sidney. These collaborations have further enriched his research and contributions to immunology.

Conclusion

Scott Southwood's innovative work in the field of immunogenic peptides has led to significant advancements in immunology. His patents reflect a deep understanding of the mechanisms of immune responses and hold promise for future therapeutic applications.